Jericho Assisted Living
Tuesday, October 11, 2016
CardioBrief: FDA Reaffirms Safety and Efficacy of Rivaroxaban
(MedPage Today) -- Faulty INR measurements didn't affect pivotal trial results, agency says
via
CardioBrief: FDA Reaffirms Safety and Efficacy of Rivaroxaban
by
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment